Since the description of a new renal syndrome in patients with the acquired immunodeficiency syndrome (AIDS) in the middle 1980s, much has been learned regarding the association of human immunodeficiency virus (HIV) infection and renal disease. The HIV-associated renal diseases represent a spectrum of clinical and histopathologic conditions. In this review, epidemiologic and clinical aspects of HIV-associated renal diseases are presented. Particular attention is placed on the pathologic and pathophysiologic mechanisms involved in HIV-associated focal glomerulosclerosis, immune complex-mediated disease, and thrombotic microangiopathies. Pharmaceutical treatment options, including the use of glucocorticoids, angiotensin-converting enzyme (ACE) inhibitors, and highly active antiretroviral therapy, are discussed. The therapeutic option of renal transplantation is presented, with insight into new clinical and basic research supporting a possible role of immunosuppressive therapy in this already immunocompromised patient population.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1046/j.1523-1755.2003.00901.x | DOI Listing |
Indian J Nephrol
July 2024
Department of Pathology, Apollo Hospitals, Hyderabad, Telangana, India.
Background: HIV infection is associated with a significant kidney disease burden. This study is aimed to screen for kidney disease in all HIV patients on highly active anti retroviral therapy (HAART), study clinico-histological correlation, and assess the impact of early diagnosis on the clinical course.
Materials And Methods: It was a prospective, longitudinal study done in a tertiary care hospital.
Afr J Infect Dis
October 2024
Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia.
Cureus
September 2024
Internal Medicine, Methodist Dallas Medical Center, Dallas, USA.
Cureus
August 2024
Nephrology, Athens Kidney Center, Oconee Medical Group, Athens, USA.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!